Bottle Label 600 mg (71610 0463 30)
Gabapentin
Product Images NDC 71610-463
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71610-463). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Figure 1 (Image 01)
This appears to be a chart or graph of some sort showing different pain scores and dose titrations. The chart includes a baseline and spans multiple weeks. The treatments being compared include a placebo and a medication called Gabapentin taken at a dose of 3600 mg/day. However, without more context or information it is difficult to determine what the chart is specifically measuring or evaluating.*
Figure 2 (Image 02)
This is a graph showing the results of a 4-week fixed dose period study of Gabapentin for pain relief. The doses used were a placebo, 1800mg/day and 2400mg/day of Gabapentin. The mean pain score was measured over the course of the 4 weeks. There are no further details provided in the text.*
Figure 3 (Image 03)
Cockcroft And Gault Equation (Image 04)
Gabapentin Structural Formula (Image 05)
Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Image 09)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
